Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2019  |  Volume : 7  |  Issue : 2  |  Page : 57-62

Current trends in the management of hydatid disease: Surgeons' perspective

1 Department of Surgery, Armed Forces Hospital Southern Region, Khamis Mushayt, Saudi Arabia
2 Department of Surgery, King Fahad Central Hospital, Jazan, Saudi Arabia
3 Department of Medicine, College of Medicine, Jazan, Saudi Arabia
4 Department of Surgery, College of Medicine, Jazan University, Jazan, Saudi Arabia; Department of Surgery, College of Medicine, Assiut University, Assiut, Egypt
5 Department of Interventional Radiology, Armed Forces Hospital Southern Region, Khamis Mushayt, Saudi Arabia

Correspondence Address:
Khaled ElShaar
Department of Surgery, King Fahad Central Hospital, B.O. 8123, Jazan 45196
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ssj.ssj_50_18

Rights and Permissions

Background: Surgery was the only known curative treatment for hydatid disease. Currently, this is being changed. Aims: The aim of this study was to explore the evolution of our management policy for hydatid disease. Patients and Methods: We retrieved records of patients with hydatid disease, treated in our unit in the period from January 1998 to February 2012. Results: Twenty-seven patients were identified. For comparison and driven by the appearance of nonsurgical means in the series, patients were divided into two groups: the first group included the first 12 patients and the second group included the last 15 patients. In the first group, all patients received surgery and only two (16.7%) received postoperative albendazole therapy. In the second group, only four patients (26.7%) received surgery with perioperative pharmacotherapy, eight patients (53.3%) received pharmacotherapy alone, and three patients (20%) received puncture-aspiration-injection-reaspiration (PAIR) with periprocedural pharmacotherapy. In those who received surgery with adjuvant pharmacotherapy, one patient died and the cyst disappeared in the remaining three. In those who received PAIR, the cyst disappeared in one case and regressed in the other two. In those who received pharmacotherapy alone, two patients showed disappearance of the cyst, one showed partial response, and five are under follow-up. Conclusions: Surgery is no longer the first-line treatment for hydatid disease. It should be reserved for complicated cases and those presenting as an emergency. When applied, surgery should be backed by pharmacotherapy which has a pivotal role, both as a sole agent and as an adjunctive to therapy.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded115    
    Comments [Add]    

Recommend this journal